Caifeng Deng

958 total citations · 1 hit paper
16 papers, 808 citations indexed

About

Caifeng Deng is a scholar working on Rheumatology, Molecular Biology and Immunology. According to data from OpenAlex, Caifeng Deng has authored 16 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 8 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Caifeng Deng's work include Immunotherapy and Immune Responses (4 papers), RNA Interference and Gene Delivery (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Caifeng Deng is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), RNA Interference and Gene Delivery (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Caifeng Deng collaborates with scholars based in China, Singapore and United States. Caifeng Deng's co-authors include Tao Gong, Zhirong Zhang, Xun Sun, Xun Sun, Mengdi Jia, Guanghua Lei, Quan Zhang, Pei Zhang, Yao Fu and Quan Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Caifeng Deng

14 papers receiving 802 citations

Hit Papers

Targeted apoptosis of macrophages and osteoclasts in arth... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caifeng Deng China 12 342 268 219 201 175 16 808
Lina Guo China 12 272 0.8× 258 1.0× 171 0.8× 103 0.5× 143 0.8× 17 782
Hee Su Sohn South Korea 11 342 1.0× 407 1.5× 206 0.9× 167 0.8× 146 0.8× 15 967
Seung Rim Hwang South Korea 16 569 1.7× 202 0.8× 102 0.5× 185 0.9× 53 0.3× 38 1.0k
In San Kim South Korea 12 273 0.8× 114 0.4× 106 0.5× 98 0.5× 90 0.5× 22 646
Yan Wei China 19 381 1.1× 296 1.1× 94 0.4× 269 1.3× 76 0.4× 28 866
Xinchun Xu China 11 419 1.2× 131 0.5× 71 0.3× 203 1.0× 43 0.2× 18 663
Ming Jia China 9 228 0.7× 127 0.5× 103 0.5× 81 0.4× 101 0.6× 12 472
Marta Benito Spain 13 126 0.4× 72 0.3× 160 0.7× 92 0.5× 108 0.6× 20 462
Huiyi Liang China 12 265 0.8× 80 0.3× 249 1.1× 49 0.2× 98 0.6× 15 644
Chenglong Ge China 13 366 1.1× 158 0.6× 107 0.5× 137 0.7× 30 0.2× 27 649

Countries citing papers authored by Caifeng Deng

Since Specialization
Citations

This map shows the geographic impact of Caifeng Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caifeng Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caifeng Deng more than expected).

Fields of papers citing papers by Caifeng Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caifeng Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caifeng Deng. The network helps show where Caifeng Deng may publish in the future.

Co-authorship network of co-authors of Caifeng Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Caifeng Deng. A scholar is included among the top collaborators of Caifeng Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caifeng Deng. Caifeng Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Deng, Caifeng, Xuan Zhao, Jian Mei, et al.. (2025). Genetically engineered chondrocyte-mimetic nanoplatform attenuates osteoarthritis by blocking IL-1β and restoring sirtuin-3. Science Advances. 11(30). eadv4238–eadv4238.
2.
Deng, Caifeng, Xuan Zhao, Hui Li, et al.. (2025). Sequential Targeting Chondroitin Sulfate‐Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages. Advanced Science. 12(9). e2411911–e2411911. 11 indexed citations
3.
Jiang, Ying, et al.. (2023). Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients. SHILAP Revista de lepidopterología. 50(9).
4.
Deng, Caifeng, Xuan Zhao, Hui Li, et al.. (2023). Apoptotic Neutrophil Membrane-Camouflaged Liposomes for Dually Targeting Synovial Macrophages and Fibroblasts to Attenuate Osteoarthritis. ACS Applied Materials & Interfaces. 15(33). 39064–39080. 23 indexed citations
5.
Yang, Yuanheng, Guanghua Lei, Chao Zeng, et al.. (2023). Pain Intensity and Trajectory Following Intra-Articular Injection of Mono-Iodoacetate in Experimental Osteoarthritis: A Meta-Analysis of In Vivo Studies. Cartilage. 14(1). 86–93. 2 indexed citations
6.
Deng, Caifeng, Xuan Zhao, Kelong Ai, et al.. (2022). Engineered Platelet Microparticle-Membrane Camouflaged Nanoparticles for Targeting the Golgi Apparatus of Synovial Fibroblasts to Attenuate Rheumatoid Arthritis. ACS Nano. 16(11). 18430–18447. 32 indexed citations
7.
Li, Haohuan, Caifeng Deng, Jianxia Dong, et al.. (2022). Chondroitin sulfate-based prodrug nanoparticles enhance photodynamic immunotherapy via Golgi apparatus targeting. Acta Biomaterialia. 146. 357–369. 38 indexed citations
8.
Deng, Caifeng, Quan Zhang, Penghui He, et al.. (2021). Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nature Communications. 12(1). 2174–2174. 195 indexed citations breakdown →
9.
Gong, Ting, Tiantian Tan, Pei Zhang, et al.. (2020). Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis. Biomaterials. 258. 120296–120296. 78 indexed citations
10.
Deng, Caifeng, Quan Zhang, Mengdi Jia, et al.. (2019). Tumors and Their Microenvironment Dual‐Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer. Advanced Science. 6(6). 1801868–1801868. 134 indexed citations
11.
Gong, Ting, Pei Zhang, Caifeng Deng, et al.. (2019). An Effective and Safe Treatment Strategy for Rheumatoid Arthritis Based on Human Serum Albumin and Kolliphor ® HS 15. Nanomedicine. 14(16). 2169–2187. 33 indexed citations
12.
Jia, Mengdi, Caifeng Deng, Jingwen Luo, et al.. (2018). A novel dexamethasone-loaded liposome alleviates rheumatoid arthritis in rats. International Journal of Pharmaceutics. 540(1-2). 57–64. 77 indexed citations
14.
Deng, Caifeng, Quan Zhang, Yao Fu, et al.. (2016). Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma. ACS Applied Materials & Interfaces. 9(2). 1280–1292. 62 indexed citations
15.
Deng, Caifeng, Mengdi Jia, Tiantian Tan, et al.. (2016). Inducing Optimal Antitumor Immune Response through Coadministering iRGD with Pirarubicin Loaded Nanostructured Lipid Carriers for Breast Cancer Therapy. Molecular Pharmaceutics. 14(1). 296–309. 33 indexed citations
16.
Zhang, Quan, Caifeng Deng, Yao Fu, et al.. (2016). Repeated Administration of Hyaluronic Acid Coated Liposomes with Improved Pharmacokinetics and Reduced Immune Response. Molecular Pharmaceutics. 13(6). 1800–1808. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026